Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma

S. S. Agarwala, J. Glaspy, S. J. O'Day, M. Mitchell, J. Gutheil, E. Whitman, R. Gonzalez, E. Hersh, L. Feun, R. Belt, F. Meyskens, K. Hellstrand, D. Wood, J. M. Kirkwood, K. R. Gehlsen, P. Naredi

Research output: Contribution to journalArticlepeer-review

146 Scopus citations

Fingerprint Dive into the research topics of 'Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences